• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA22-80/I16-40
Medical Device Problem Code Complete Blockage (1094)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 11/05/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2, device remains implanted.
 
Event or Problem Description
The patient was initially implanted with an afx2 bifurcated stent graft and vela infrarenal to treat an abdominal aortic aneurysm (aaa).Approximately (2) two years after post initial procedure the patient was identified as having stent thrombosis.It was confirmed that occlusion of the afx stent graft with a collateral filling of external iliac arteries had occurred.The patient is being monitored.
 
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident-related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the aortic occlusion is confirmed.This is consistent with the reported adverse event/incident.The most likely causation for the occlusion is user-related due to a concomitant thoracic aneurysm before the index procedure and the proximal neck pre-index measurement being 15.6mm (cautionary product use per ifu requirement 18-32mm).Procedure-related harms for this complaint could not be determined.The final patient status was reported as being under surveillance.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.Corrections: h6 evaluation result codes; remove 3233.H6 evaluation conclusion codes; remove 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Common Device Name
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key11904717
Report Number2031527-2021-00211
Device Sequence Number4404134
Product Code MIH
UDI-Device Identifier00818009015006
UDI-Public(01)00818009015006(17)190409
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 04/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/09/2019
Device Model NumberBEA22-80/I16-40
Device Lot Number1925398-002
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 04/28/2021
Supplement Date Received by Manufacturer05/27/2021
Initial Report FDA Received Date05/28/2021
Supplement Report FDA Received Date07/12/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
VELA INFRARENAL (B)(6)
Outcome Attributed to Adverse Event Other;
Patient Age63 YR
-
-